BRIEF-Opus Genetics Announces Updates On Opgx-Lca5 Clinical Program

Reuters
18 Feb
BRIEF-Opus Genetics Announces Updates On Opgx-Lca5 Clinical Program

Feb 18 (Reuters) - Opus Genetics Inc IRD.O:

  • OPUS GENETICS ANNOUNCES UPDATES ON OPGX-LCA5 CLINICAL PROGRAM

  • OPUS GENETICS INC: FDA MEETING SCHEDULED IN MARCH 2025 TO DISCUSS PHASE 3 TRIAL DESIGN AND REGISTRATIONAL ENDPOINTS FOR OPGX-LCA5

  • OPUS GENETICS INC: INITIAL DATA ON COHORT ANTICIPATED BY Q3 2025

Source text: ID:nGNX96nTcP

Further company coverage: IRD.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10